Inventor · disambiguated record
Yun Kang
Also filed as: KANG YUN · KANG YUN KENNETH
3 granted patents·3 pending applications·86 citations·filing 2006–2015
74Inventor score
Files withPROGENICS PHARM INC2MA DANGSHE1NEOSE TECHNOLOGIES INC1PROGENICS PHARMACEUTICAL INC AND CORNELL RES FOUNDATION INC1WYETH LLC1
Top patents by PatentIndex Score
6 records- 0193US7939083B2Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomainPROGENICS PHARM INC·Filed 2007·Granted May 10, 2011·55 cites·21 claims
- 0289US8986697B2Antibodies for the treatment of Clostridium difficile-associated infection and diseaseMA DANGSHE·Filed 2011·Granted Mar 24, 2015·23 cites·24 claims
- 0373US7875446B2Purification processes for isolating purified vesicular stomatitis virus from cell cultureWYETH LLC·Filed 2007·Granted Jan 25, 2011·8 cites·20 claims
- 0440US2011250220A1Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereofPROGENICS PHARMACEUTICAL INC AND CORNELL RES FOUNDATION INC·Filed 2011·Application pending·0 cites
- 0540US2006246544A1Manufacturing process for the production of peptides grown in insect cell linesNEOSE TECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 0639US2015175681A1Antibodies for the treatment of clostridium difficile-associated infection and diseasePROGENICS PHARM INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yun Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →